CIK 0001420720
- Non-accelerated filer
- Smaller reporting company
iBio, Inc.
Sign in to watch- Ticker
- IBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262797813
- Phone
- +1 302-355-0650
- Business address
- 600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
- Former names
- iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-09-15 | DESANTIS CARL 10% owner | Sale | −53,130 | $0.60 | $32K | 5,836,723 |
| 2014-09-05 | FLUG SEYMOUR Director | Grant or award · Stock Option (right to buy) | +60,000 | $0.49 | $29K | 180,000 |
| 2014-09-05 | Kay Robert Executive Chairman and CEO | Grant or award · Stock Option (right to buy) | +600,000 | $1.00 | $600K | 3,300,000 |
| 2014-09-05 | ERWIN ROBERT L President | Grant or award · Stock Option (right to buy) | +600,000 | $1.00 | $600K | 2,300,000 |
| 2014-09-05 | RUSSELL PHILIP K. Director | Grant or award · Stock Option (right to buy) | +60,000 | $0.49 | $29K | 300,000 |
| 2014-09-05 | GIANNONE MARK A Chief Financial Officer | Grant or award · Stock Option (right to buy) | +50,000 | $0.49 | $25K | 150,000 |
| 2014-09-05 | MCKEY JOHN D JR Director | Grant or award · Stock Option (right to buy) | +60,000 | $0.49 | $29K | 490,000 |
| 2014-09-05 | GENERAL HILL (Ret) JAMES T. Director | Grant or award · Stock Option (right to buy) | +60,000 | $0.49 | $29K | 390,000 |
| 2014-09-05 | Elliott Arthur Y Director | Grant or award · Stock Option (right to buy) | +60,000 | $0.49 | $29K | 300,000 |
| 2014-09-05 | Chang Glenn Director | Grant or award · Stock Option (right to buy) | +60,000 | $0.49 | $29K | 390,000 |
| 2014-02-03 | DESANTIS CARL 10% owner | Sale | −28,828 | $0.55 | $16K | 5,889,853 |
| 2014-01-31 | DESANTIS CARL 10% owner | Sale | −54,889 | $0.56 | $31K | 5,918,681 |
| 2014-01-31 | DESANTIS CARL 10% owner | Sale | −54,889 | $0.56 | $31K | 5,949,314 |
| 2014-01-30 | DESANTIS CARL 10% owner | Sale | −19,160 | $0.55 | $11K | 5,973,570 |
| 2014-01-30 | DESANTIS CARL 10% owner | Sale | −19,160 | $0.55 | $11K | 6,004,203 |
| 2014-01-29 | DESANTIS CARL 10% owner | Sale | −21,479 | $0.56 | $12K | 5,992,730 |
| 2014-01-29 | DESANTIS CARL 10% owner | Sale | −21,479 | $0.56 | $12K | 6,023,363 |
| 2014-01-28 | DESANTIS CARL 10% owner | Sale | −60,381 | $0.55 | $33K | 6,014,209 |
| 2014-01-28 | DESANTIS CARL 10% owner | Sale | −60,381 | $0.55 | $33K | 6,044,842 |
| 2014-01-24 | GIANNONE MARK A Chief Financial Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 |
Page 17 of 22 · 423 trades